Managers

Arixa Pharmaceuticals pulls in $8 mln seed

Palo Alto, California-based Arixa Pharmaceuticals Inc, a developer of oral antibiotics, has raised $8 million in seed financing. The investors in this round were not named.

Marketing outlays a key part of growth-stage firms: Edison Partners survey

Pre-money valuations hold at high levels in Q1

The demographics of venture hubs

Venture’s rise of the rest

Halo Neuroscience procures $1 mln from FPC

Future Planet Capital has acquired a stake in Halo Neuroscience for $1 million. Based in San Francisco, Halo Neuroscience is a creator of Halo Sport, a neurostimulation headset.

Sky9 Capital raises $200 mln for third fund

Sky9 Capital, a China-focused venture firm, has closed its third fund at a hard cap of $200 million. The fund's limited partners include institutional investors, family foundations and entrepreneurs.

Datavant inks $40.5 mln, also acquires Universal Patient Key

San Francisco-based Datavant, which helps healthcare organizations safely link their data to improve medical research and patient care, has raised $40.5 million in financing. The lead investors were Roivant Sciences and Travis May. Also, Datavant has acquired Universal Patient Key, a provider of HIPAA-compliant de-identification services for healthcare data. No financial terms were disclosed.

Attenua Inc nabs $35 mln Series A

Attenua Inc, a developer of new chronic cough treatments, has closed $35 million in Series A financing. Omega Funds led the round with participation from investors that included Abingworth, OrbiMed and Redmile Group LLC.

Andra Capital collects over $500 mln for fund

San Francisco-based Andra Capital has raised more than $500 million for its blockchain-focused late-stage technology growth fund. According to the company, it expects to raise $1 billion for the pool.